S. Haffner
Circulation · 2000–2015
A researcher in the Science corpus: 15 papers; trusts 0 researchers and is trusted by 10 researchers here, as inferred from the citation graph.
Whom S. Haffner trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts S. Haffner overall
- Christoph Handschin
- Paula Pereira
- J. Pickup
- Ralph DeFronzo
- P. Ridker
- B. Spiegelman
- E. Ford
- Bart Staels
- S. Grundy
Papers from S. Haffner's perspective
Ordered by how strongly the researchers S. Haffner trusts endorse each paper. Same corpus, a different order for every researcher.
- Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. (Journal of the American Medical Association (JAMA))
- The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. (Journal of the American Medical Association (JAMA))
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. (The Lancet)
- Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. (American Journal of Clinical Nutrition)
- Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. (Journal of the American Medical Association (JAMA))
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. (The Lancet)
- Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis
- Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice
- Perceived Exertion (Sports Medicine)
- Effect of exercise duration and intensity on weight loss in overweight, sedentary women: a randomized trial. (Journal of the American Medical Association (JAMA))
Their papers
- Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus (2002) — 897 citations
- The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial (2005) — 998 citations
- Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? (2004) — 784 citations
- National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2015) — 5,427 citations
- Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes (2007) — 1,589 citations
- International Day for the Evaluation of Abdominal Obesity (IDEA): A Study of Waist Circumference, Cardiovascular Disease, and Diabetes Mellitus in 168 000 Primary Care Patients in 63 Countries (2007) — 798 citations
- The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. (2006) — 611 citations
- Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial. (2006) — 717 citations
- The prevalence of diabetic retinopathy among adults in the United States. (2004) — 1,189 citations
- National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study (2004) — 701 citations
- The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. (2003) — 876 citations
- Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. (2002) — 1,180 citations
- Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. (2002) — 671 citations
- The relation of body fat mass and distribution to markers of chronic inflammation (2001) — 761 citations
- Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). (2000) — 2,583 citations